Healthcare & Pharmaceuticals Brands

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.

Acuvue is the world's leading contact lens brand, owned by Johnson & Johnson Vision Care, a division of Johnson & Johnson. The brand covers daily, weekly, and monthly disposable soft contact lenses sold in more than 100 countries.

Prescription antibody-drug conjugate treatment for classical Hodgkin lymphoma and CD30-expressing peripheral T-cell lymphomas, co-developed by Seagen and licensed to Takeda Pharmaceutical.

American managed care and health insurance company offering medical, dental, pharmacy, and behavioral health plans, operating as a subsidiary of CVS Health Corporation.

Prescription oncology medicine (everolimus) used to treat certain cancers and tuberous sclerosis complex, developed and marketed by Novartis AG.

Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.

Prescription stem cell therapy originally approved in Europe for treating complex perianal fistulas in adult Crohn's disease patients, developed by TiGenix and acquired by Takeda.

Amazon's online pharmacy service offering prescription medications and home delivery, operating as a division of Amazon.com Inc.

Legacy brand name of Cencora Inc., one of the largest pharmaceutical distributors in the United States, formed through a 2001 merger and rebranded to Cencora in August 2023.

Health insurance brand providing medical, pharmacy, behavioral, and dental coverage to individuals and employers, owned by Elevance Health.

Health insurance brand providing medical, pharmacy, behavioral, and dental coverage to individuals and employers, owned by Elevance Health.

Sanofi Genzyme's oral disease-modifying therapy (teriflunomide) for relapsing forms of multiple sclerosis, FDA approved September 12, 2012, that works by inhibiting dihydroorotate dehydrogenase (DHODH) to selectively reduce proliferating lymphocytes driving MS inflammation.

Groundbreaking anti-VEGF biologic cancer therapy (bevacizumab) developed by Genentech and owned by Roche, FDA approved February 26, 2004, that reached peak global sales of $7.1 billion in 2019 and now faces biosimilar competition including Mvasi (Amgen) and multiple other approved alternatives.

Bausch Health's branded azathioprine tablet (75 mg and 100 mg strengths), distributed by Salix Pharmaceuticals (a division of Bausch Health US, LLC) and manufactured by Alcami Corporation, indicated for renal transplant rejection prevention and severe rheumatoid arthritis, based on the immunosuppressant azathioprine originally developed by Nobel laureate Gertrude Elion at Burroughs Wellcome in the 1950s.

American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.

Walmart's private label personal care brand offering affordable everyday essentials including health, beauty, and wellness products.

Global eye health company and contact lens manufacturer founded in 1853, known for ULTRA, Biotrue One Day, and INFUSE lens lines. Public on NYSE and TSX under BLCO.

American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.

Independent specialty pharmacy providing personalized patient care for oncology and rare disease treatments owned by McKesson Corporation.

Prescription medication for reversing neuromuscular blockade during anesthesia, manufactured and marketed by Merck & Co.

Prescription combination drug containing amlodipine and atorvastatin, co-promoted by Pfizer and developed for simultaneous blood pressure and cholesterol management.

At-home healthcare solutions division of Cardinal Health, delivering medical supplies and pharmacy services directly to patients across the United States.

Nuclear and precision health solutions division of Cardinal Health, supplying radiopharmaceuticals, diagnostic imaging agents, and theranostics to hospitals and clinical research networks.

Specialty pharmacy division of Cardinal Health, providing distribution and management services for high-cost, complex medications used in oncology, rheumatology, and other specialty therapeutic areas.

American feminine hygiene brand producing panty liners and feminine care products, now owned by Essity, a Swedish global hygiene and health company.

Healthcare services subsidiary of Elevance Health, providing behavioral health administration, medical benefit management, and payment integrity services to health plans and employers.

Pharmacy benefit manager owned by CVS Health, administering prescription drug benefits for employers and health plans. In July 2026, Caremark reached a settlement with the FTC over insulin pricing and rebate practices.

Prescription COX-2 inhibitor anti-inflammatory medication for treating arthritis pain, originally developed by G.D. Searle & Company and now marketed by Pfizer.

Prescription immunosuppressant medication (mycophenolate mofetil) for preventing organ rejection in transplant recipients, originally developed by Syntex Laboratories and now marketed by Roche.

Centene Corporation's Medicare Advantage and prescription drug plan offerings, primarily delivered through the WellCare brand following Centene's $17.3 billion acquisition of WellCare Health Plans in January 2020, making Centene one of the largest Medicare Advantage operators in the United States.

Molecular diagnostics company specializing in point-of-care PCR testing systems, owned by Danaher Corporation.

Bivalent HPV vaccine targeting HPV types 16 and 18, developed by GSK. Discontinued in most markets as part of GSK portfolio rationalization.

Healthcare technology company providing claims processing and payment solutions, owned by UnitedHealth Group.

Prescription smoking cessation medication (varenicline) developed by Pfizer, FDA-approved in 2006.

Australian discount pharmacy chain and the largest retail pharmacy franchisor in Australia. Owned by Sigma Healthcare Limited following a merger completed in February 2025.

Dental insurance brand offered by The Cigna Group, providing individual, family, and employer-sponsored dental plans across the United States. Cigna Group reported $71.7 billion in Q2 2026 revenue.

American health insurance brand providing medical coverage, health plans, and wellness services for individuals, families, and employers through The Cigna Group.

American pharmacy services brand providing prescription drug coverage, medication management, and pharmacy benefits through The Cigna Group's Evernorth Health Services division.

Contact lens brand owned by Menicon, headquartered in Singapore, producing biocompatible daily disposable and monthly silicone hydrogel lenses for Asia-Pacific and global markets.

Global contact lens manufacturer and division of CooperCompanies, known for Biofinity, MyDay, Clariti, and MiSight myopia management lenses. Strong in toric and multifocal fittings.

American specialty pharmacy and home infusion services provider, owned by CVS Health since 2014. Coram serves patients with complex conditions requiring specialized infusion therapy.

Prescription biologic medication treating psoriasis, psoriatic arthritis, and other autoimmune conditions.

Prescription blood pressure medication, the first angiotensin II receptor blocker, approved by the FDA in 1995.

American pharmacy retail chain and one of the largest pharmacy networks in the United States, owned by CVS Health.

Prescription medication for treating hepatic veno-occlusive disease (sinusoidal obstruction syndrome) following hematopoietic stem-cell transplantation, marketed by Jazz Pharmaceuticals.

Desmoteplase is an investigational thrombolytic derived from vampire bat saliva, developed for acute ischemic stroke in an extended 3 to 9 hour treatment window. Owned by Lundbeck. Not approved by any regulatory authority.

Prescription proton pump inhibitor (dexlansoprazole) for treating GERD and erosive esophagitis, manufactured by Takeda Pharmaceutical Company.

Prescription antifungal medication (fluconazole) for treating candidiasis, cryptococcal meningitis, and other fungal infections. Developed by Pfizer, FDA-approved in 1990.